17:43 , Nov 16, 2018 |  BC Week In Review  |  Financial News

Synthorx proposes $100M IPO ahead of synthetic IL-2 clinical testing

Synthetic biology company Synthorx Inc. (La Jolla, Calif.) proposed to raise $100 million in a NASDAQ IPO, according to an SEC filing from Nov. 13. Synthorx is using synthetic biology to develop a pipeline of...
00:36 , Nov 7, 2018 |  BC Extra  |  Company News

Management tracks: Five Prime, Alder

Five Prime Therapeutics Inc. (NASDAQ:FPRX) hired David Smith as EVP and CFO, effective Nov. 26. He will replace Linda Rubinstein, who was interim CFO of the cancer company. Smith was COO of IntegenX Inc. until...
16:42 , Jul 6, 2018 |  BC Week In Review  |  Company News

Athenex Announces Two China Deals Plus $100M Raise

Athenex Inc. (NASDAQ:ATNX) entered into a pair of deals with Chinese partners on a newsy July 2 that also saw the biotech raise $100 million in equity and debt. The company said it is forming...
23:18 , Jul 2, 2018 |  BC Extra  |  Company News

Athenex announces two China deals plus $100M raise

Athenex Inc. (NASDAQ:ATNX) entered into a pair of deals with Chinese partners on a newsy Monday that also saw the biotech raise $100 million in equity and debt. The company said it is forming a...
16:20 , May 4, 2018 |  BC Week In Review  |  Financial News

Synthorx raises $63M in series C

Synthorx Inc. (La Jolla, Calif.) raised $63 million on April 30 in a series C round led by new investor OrbiMed Advisors. Fellow new investors Medicxi and Osage University Partners also participated in the round,...
17:29 , Apr 30, 2018 |  BC Extra  |  Financial News

Synthorx raises $63 million in series C

Synthorx Inc. (La Jolla, Calif.) raised $63 million in a series C round led by new investor OrbiMed Advisors. Fellow new investors Medicxi and Osage University Partners also participated in the round, as did existing...
17:48 , Mar 23, 2018 |  BC Week In Review  |  Financial News

TCR2 raises $125M series B

TCR2 Therapeutics Inc. (Cambridge, Mass.) raised an untranched $125 million series B round on March 21 led by 6 Dimensions Capital and Curative Ventures and joined by fellow new investors Redmile Group, ArrowMark Partners, Hillhouse...
12:00 , Mar 21, 2018 |  BC Extra  |  Financial News

TCR2 raises $125M series B

TCR2 Therapeutics Inc. (Cambridge, Mass.) raised an untranched $125 million series B round led by 6 Dimensions Capital and Curative Ventures and joined by fellow new investors Redmile Group, ArrowMark Partners, Hillhouse Capital, MiraeAsset Financial...
22:36 , Feb 9, 2018 |  BioCentury  |  Finance

Elites always welcome

The fact that 69 biotechs have raised $6.1 billion via IPO financings on NASDAQ since the start of 2016 might suggest the IPO window has remained wide open in the U.S. A closer look at...
19:51 , Dec 15, 2017 |  BC Week In Review  |  Financial News

Jnana launches with $50M series A

On Dec. 14, Jnana Therapeutics Inc. (Boston, Mass.) launched with a $50 million series A round from existing investors Polaris Partners and Avalon Ventures and new investors Versant Ventures, AbbVie Ventures and Pfizer R&D Innovate....